Molecular Tumor Board: 75-year-old male presents with a several month history of a painful tongue lesion and weight loss

In this Molecular Tumor Board we review cases of oral cavity squamous cell carcinoma and explore the clinical utility of lymphatic fluid collected from surgical drains as a novel source of ctDNA. This innovative approach from Droplet Biosciences offers potential for more precision monitoring and personalized treatment strategies. 

Presented by:

Wendy Winckler, PhD
Chief Science Officer
Droplet Biosciences

Jose Zevallos, MD, MPH
Scientific Co-founder
Droplet Biosciences

Michelle Green, PhD
Senior Manager, Genomics Program
Labcorp Oncology